Neuro Spectrum Insights, Inc. plans to list on the NYSE American under the symbol NSIH, offering 3,750,000 shares of common stock, at $4.00 to $5.00 a share. It filed a Form S-1 registration statement for an initial public offering on June 20, 2025. As of November 6, 2026, its registration is amended and on file (Form S-1/A, October 5, 2026).
Sell to companies like Neuro Spectrum Insights, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
Neuro Spectrum Insights, Inc. filed a Form S-1 registration statement for an initial public offering on 2025-06-20. It has amended it 7 times. As of its latest filing, on 2026-10-05, it has not priced the offering or withdrawn it. Each fact below is quoted from the filing named with it.
What the filings say
Listing
We have applied to list our Common Stock on the New York Stock Exchange American (“NYSE American”), under the symbol “NSIH”.From the S-1/A filed 2026-10-05
Shares offered
This is the initial public offering of 3,750,000 shares of common stock par value $0.00001 per share (the “Common Stock”) of NeuroSpectrum Insights, Inc. Prior to this offering there has been no public market for our Common Stock.From the S-1/A filed 2026-10-05
Price range
We currently expect the initial public offering price to be between $4.00 and $5.00 per share, with a $4.50 assumed initial public offering price (which is the midpoint of the $4.00 to $5.00 range; this assumption is used throughout this prospectus).From the S-1/A filed 2026-10-05
Underwriters
Network 1 Financial Securities, Inc. is acting as the sole book -running manager of the offering and as representative of the underwriters.From the S-1/A filed 2026-10-05
Use of proceeds
We intend to use the net proceeds from this offering, after commissions and before offering expenses, as follows:From the S-1/A filed 2026-10-05
Net loss or income
During 2024, 2025 and the first two quarters in 2026 we incurred net losses of approximately $2,649,000, $1,826,000 and $1,125,991, respectively, due primarily to personnel and professional services expenses, interest expenses and product development costs.From the S-1/A filed 2026-10-05
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2025-06-20 | Registration statement filed | S-1 |
| 2025-09-24 | Registration statement amended | S-1/A |
| 2026-01-23 | Registration statement amended | S-1/A |
| 2026-04-06 | Registration statement amended | S-1/A |
| 2026-05-05 | Registration statement amended | S-1/A |
| 2026-07-10 | Registration statement amended | S-1/A |
| 2026-07-30 | Registration statement amended | S-1/A |
| 2026-10-05 | Registration statement amended | S-1/A |
Check before you invest in Neuro Spectrum Insights, Inc.: the warning signs and who's behind it, free.
Free to see. No signup.
Keep reading
More on Neuro Spectrum Insights, Inc. and the records around it.
Also filing to list on the NYSE American
IPO filings on the NYSE American in Q4 2026, newest first.
- NuvOx Therapeutics, Inc. (Oct 2026)
- Ambitious Entertainment, Inc. (Oct 2026)
Watch Neuro Spectrum Insights, Inc.
Get an email when Neuro Spectrum Insights, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Neuro Spectrum Insights, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Neuro Spectrum Insights, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Neuro Spectrum Insights, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Tools for this story
Each opens in a new tab, filled in for Neuro Spectrum Insights, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.